Dupont Nutrition Biosciences Aps

Danisco US Inc.

Cherry Lin

Michael C Ward

Susan Mampusti Madrid

Masoud Rajabi Zargahi

Mai Faurschou Isaksen

Rikke Høegh Lorentsen

Nigel S Dunn-Coleman

Michael D Ward

Benjamin S Bower

Suzanne E Lantz

Peter Plumstead

Luis Fernando Romero Millan

Susan M Madrid

Rikke Hoegh Lorentsen

Luis Fernando Romero Millán

Luis Fernando Romero MILLÁN

Susan Madrid

The present invention provides a transformed or transfectedcell comprising one or more of: (i) at least one heterologous nucleotide sequence encoding a lipolytic enzyme comprising an amino acid sequence shown as SEQ ID NO: 1 or SEQ ID NO: 2, (ii) at least one heterologous nucleotide sequence encoding a lipolytic enzyme wherein the nucleotide sequence comprises the nucleotide sequence shown as SEQ ID NO: 3 or SEQ ID NO: 4, or (iii) at least one heterologous nucleotide sequence encoding a lipolytic enzyme wherein the nucleotide sequence comprises the nucleotide sequence which hybridizes to SEQ ID NO: 3 or SEQ ID NO: 4 or a nucleotide sequence which is at least 40% sequence identity to SEQ ID NO: 3 or SEQ ID NO: 4; and culturing the cell under conditions to allow for expression of the heterologous nucleotide sequence(s) encoding the lipolytic enzyme.

Method of producing a lipolytic enzyme

The present invention provides a transformed or transfectedcell comprising one or more of: (i) at least one heterologous nucleotide sequence encoding a lipolytic enzyme comprising an amino acid sequence shown as SEQ ID NO: 1 or SEQ ID NO:2, (ii) at least one heterologous nucleotide sequence encoding a lipolytic enzyme wherein the nucleotide sequence comprises the nucleotide sequence shown as SEQ ID NO: 3 or SEQ ID NO: 4, or (iii) at least one heterologous nucleotide sequence encoding a lipolytic enzyme wherein the nucleotide sequence comprises the nucleotide sequence which hybridizes to SEQ ID NO: 3 or SEQ ID NO: 4 or a nucleotide sequence which is at least 40% sequence identity to SEQ ID NO: 3 or SEQ ID NO: 4; and culturing the cell under conditions to allow for expression of the heterologous nucleotide sequence(s) encoding the lipolytic enzyme.

The present invention relates to a polypeptide having alpha-amylase activity obtained from a strain of

Polypeptides having alpha-amylase and granular starch hydrolyzing activity

The present invention relates to a feed supplement comprising a phytase and a lipolytic enzyme, wherein said lipolytic enzyme has lipase activity at a pH in the range of about pH1.5 to about pH3.5.

Feed supplement with lipase and phytase

Feed supplement

Growing community of inventors

Sunnyvale, CA, United States of America

Cherry Lin